scholarly journals Excellent results for atrial fibrillation surgery in the presence of giant left atrium and mitral valve disease*1

2004 ◽  
Author(s):  
S CHOO
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Giant Left Atrium

scholarly journals Excellent results for atrial fibrillation surgery in the presence of giant left atrium and mitral valve disease☆

2004 ◽  
Vol 26 (2) ◽  
pp. 336-341 ◽  
Author(s):  
Suk Jung Choo ◽  
Nam Hee Park ◽  
Sang Kwon Lee ◽  
Jong Woo Kim ◽  
Jae Kwan Song ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Giant Left Atrium

A modified maze procedure performed only on the left atrium for chronic atrial fibrillation associated with mitral valve disease: Report of a case

Surgery Today ◽  
1996 ◽  
Vol 26 (2) ◽  
pp. 135-137 ◽  
Author(s):  
Taijiro Sueda ◽  
Hiroo Shikata ◽  
Kazumasa Orihashi ◽  
Norimasa Mitsui ◽  
Hideyuki Nagata ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Chronic Atrial Fibrillation ◽  
Valve Disease ◽  
Maze Procedure

scholarly journals GIANT LEFT ATRIUM THROMBOSIS ASSOCIATED WITH AN ASYMPTOMATIC MITRAL VALVE DISEASE

2020 ◽  
Vol 10 (1) ◽  
pp. 238-244
Author(s):  
E.V. Reznik ◽  
◽  
M.S. Komissarova ◽  
D.V. Ustyuzhanin ◽  
I.G. Nikitin ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Giant Left Atrium

scholarly journals CONCOMITANT PROCEDURE OF ATRIAL FIBRILLATION ABLATION WITH AND WITHOUT LEFT ATRIOPLASTY DURING SURGICAL CORRECTION OF THE MITRAL VALVE DISEASE: PROSPECTIVE, RANDOMIZED TRIAL

2018 ◽  
Vol 33 (3) ◽  
pp. 63-70
Author(s):  
A. V. Bogachev-Prokophiev ◽  
S. I. Zheleznev ◽  
M. A. Ovcharov ◽  
A. V. Afanasyev ◽  
R. M. Sharifulin ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Left Atrial ◽  
Valve Disease ◽  
Atrial Ablation ◽  
Group I ◽  
Group Ii

Objective. Main objective of this prospective randomized study was to assess safety and efficiency of the combined approach for the left atrial ablation in combination with and without reduction left atrioplasty in patients with mitral valve disease.Material and Methods. The study was performed from September, 2014 to February, 2017. A total of 120 patients with mitral valve disease, permanent atrial fibrillation (AF), and left atriomegaly were enrolled in the study. Patients were randomized to two groups: group I comprised patients who received correction of mitral valve disease in combination with AF ablation and without reduction atrioplasty of the left atrium (MV+MAZE); group II (n=60) comprised patients with correction of mitral valve disease in combination with AF ablation and with reduction atrioplasty of the left atrium (MV+MAZE+AP). Patient characteristics did not differ between groups.Results. There were no significant differences between groups in the early mortality rates (2 patients in group I versus 5 patients in group II, p=0.64); bleeding rates (total 5 cases including 2 patients in group I and 3 patients in group II, p=0.34), and the rates of AF recurrence in the early postoperative period. Permanent pacemakers were implanted in 8 patients (13.3%) of group I and in 4 patients (6.7%) of group II. Total long-term mortality was 4 patients including 1 and 3 patients in group I and II, respectively, which did not significantly differed. The rates of one-year freedom from AF were 84.8 and 86.2% in group I and II, respectively. No new onsets of atrial fibrillation were observed for 36 months in both groups. The rates of freedom from thromboembolic events during the time of observation were 88.6% in group I and 96.5% in group II. Conclusion. The left atrial reduction concomitant with the left atrial ablation and correction of mitral valve disease is safe and effective procedure. However, this procedure did not impact the rates of long-term freedom from AF.

Concomitant Left Atrial Reduction in Rheumatic Mitral Valve Disease with Giant Left Atrium

2018 ◽  
Vol 13 (5) ◽  
pp. 349-355 ◽  
Author(s):  
Sudhir Adalti ◽  
Kartik G. Patel ◽  
Chirag P. Doshi ◽  
Chandrashekhar Ananthnarayanan ◽  
Chintan N. Mehta ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Normal Sinus Rhythm ◽  
Heart Association ◽  
Persistent Atrial Fibrillation ◽  
Valve Disease ◽  
Aortic Cross Clamp Time ◽  
Giant Left Atrium ◽  
The Mean

Objective The giant left atrium is a frequent finding with rheumatic heart disease. The enlarged left atrium was found to be a risk factor for early mortality and postoperative higher thromboembolic events, but its management remains controversial. Most of the surgeons just do the mitral valve procedure without any intervention for enlarged left atrium. We present our center's experience of patients with giant left atrium who underwent a newer technique of left atrium reduction concomitant with mitral valve procedure. Methods Between January 2012 and February 2015, 25 patients, who underwent surgery for concomitant left atrium reduction with mitral valve disease, were included in the study after institute's ethics committee clearance. Patients having combined aortic and mitral valve disease were excluded. Preoperative, intraoperative, and postoperative data were collected. All the patients were also followed up clinically and echocardiographically in postoperative period. Results There were 15 (60%) females. The mean ± SD age of the patients was 36.92 ± 5.4 years. Preoperatively, all patients were in long-standing persistent atrial fibrillation. The mean ± SD bypass and aortic cross-clamp time were 74.56 ± 3.85 and 51.72 ± 4.32 minutes, respectively. There was a significant reduction of left atrium diameter and volume from 94.48 ± 11.0 mm to 40.08 ± 1.35 mm and 348.3 ± 121.1 to 26.57 ± 2.9 mL/m2, respectively. There was no early or late mortality. At a mean ± SD follow-up of 42.28 ± 12.1 months, all patients were in New York Heart Association I or II class and 24 (96%) patients were in normal sinus rhythm. Conclusions Concurrent left atrium reduction with mitral valve procedure is a feasible and effective technique for event-free survival of the patients having giant left atrium with mitral disease.

Resection of Giant Left Atrium in Mitral Valve Disease

2014 ◽  
Vol 23 (1) ◽  
pp. e51
Author(s):  
Krishna Bhagwat ◽  
Johann Brink ◽  
Igor E. Konstantinov ◽  
Bryn Jones ◽  
Yves d’Udekem ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Giant Left Atrium

Giant Left Atrium Secondary to Rheumatic Mitral Valve Disease

2006 ◽  
Vol 15 (4) ◽  
pp. 253-254 ◽  
Author(s):  
Konstantinos P. Letsas ◽  
Antonios Sideris ◽  
Stavros P. Kounas ◽  
Loucas K. Pappas ◽  
Fotios Kardaras
Keyword(s):  
Mitral Valve ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Giant Left Atrium

scholarly journals Giant left atrium in undersized mitral ring annuloplasty

2016 ◽  
Vol 86 (1-2) ◽  
Author(s):  
Nicole Bertin ◽  
Aniello Pappalardo ◽  
Alessandro Minati ◽  
Gabriella Forti ◽  
Serena Favretto ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Mitral Regurgitation ◽  
Left Atrium ◽  
Mitral Valve Disease ◽  
Volume Overload ◽  
Valve Disease ◽  
Severe Mitral Regurgitation ◽  
Unique Case ◽  
Ring Annuloplasty ◽  
Giant Left Atrium

<p>Enlargement of left atrium occurs in patients with longstanding mitral valve disease due to chronic pressure and volume overload and occasionally left atrium reaches a massive enlargement, condition known as giant left atrium. It is most commonly associated with rheumatic mitral valve disease, both stenosis and regurgitation. This unique case deals with a 70-year-old woman who developed a giant left atrium due to a severe mitral regurgitation from complete prolapse of both mitral leaflets, as a consequence of previous undersized mitral ring annuloplasty. </p>

Sign in / Sign up

Export Citation Format

Share Document